Green Pine Leads Series Pre-B Plus Round In Chinese Genome Editing Firm EdiGene

Login to View

Chinese genome editing technologies developer EdiGene Inc. has secured about US$10 million in its series pre-B plus round of financing led by Chinese venture capital firm Green Pine Capital Partners, said EdiGene in a statement released on Monday.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Read 3 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription for $359

Enjoy comprehensive and exclusive data you can't find elsewhere!

Subscribe for $359


Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in

China Money Network Subscription

RELATED NEWS